These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1855 related items for PubMed ID: 24293164

  • 1. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S, Kumari S, Fallang LE, Sand KM, Yang W, Landsverk OJ, Bakke O, Olweus J, Gregers TF.
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [Abstract] [Full Text] [Related]

  • 2. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A, Heirman C, Tuyaerts S, Michiels A, Zhang Y, van der Bruggen P, Thielemans K.
    Cancer Res; 2003 Sep 01; 63(17):5587-94. PubMed ID: 14500399
    [Abstract] [Full Text] [Related]

  • 3. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
    André F, Chaput N, Schartz NE, Flament C, Aubert N, Bernard J, Lemonnier F, Raposo G, Escudier B, Hsu DH, Tursz T, Amigorena S, Angevin E, Zitvogel L.
    J Immunol; 2004 Feb 15; 172(4):2126-36. PubMed ID: 14764678
    [Abstract] [Full Text] [Related]

  • 4. MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.
    Malcherek G, Wirblich C, Willcox N, Rammensee HG, Trowsdale J, Melms A.
    Eur J Immunol; 1998 May 15; 28(5):1524-33. PubMed ID: 9603457
    [Abstract] [Full Text] [Related]

  • 5. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
    Rojas JM, Rodríguez-Calvo T, Peña L, Sevilla N.
    Vaccine; 2011 Sep 16; 29(40):6848-57. PubMed ID: 21807057
    [Abstract] [Full Text] [Related]

  • 6. Endosomal compartment: Also a dock for MHC class I peptide loading.
    Ma W, Van den Eynde BJ.
    Eur J Immunol; 2014 Mar 16; 44(3):650-3. PubMed ID: 24515851
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
    Adams S, Humphreys RE.
    Eur J Immunol; 1995 Jun 16; 25(6):1693-702. PubMed ID: 7614997
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
    Preta G, Marescotti D, Fortini C, Carcoforo P, Castelli C, Masucci M, Gavioli R.
    Scand J Immunol; 2008 Dec 16; 68(6):579-88. PubMed ID: 19000094
    [Abstract] [Full Text] [Related]

  • 13. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
    Tomita Y, Yuno A, Tsukamoto H, Senju S, Kuroda Y, Hirayama M, Irie A, Kawahara K, Yatsuda J, Hamada A, Jono H, Yoshida K, Tsunoda T, Kohrogi H, Yoshitake Y, Nakamura Y, Shinohara M, Nishimura Y.
    Clin Cancer Res; 2013 Aug 15; 19(16):4508-20. PubMed ID: 23714729
    [Abstract] [Full Text] [Related]

  • 14. N-terminal functional region of the invariant chain efficiently targets the binding of a CTL epitope to MHC class I molecules during cross-presentation.
    Wu C, Zhang DG, Chen FF, Liu XL, Liu SJ, Yu WY.
    Genet Mol Res; 2014 Apr 03; 13(2):2438-50. PubMed ID: 24781998
    [Abstract] [Full Text] [Related]

  • 15. Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells.
    Tsuji T, Matsuzaki J, Caballero OL, Jungbluth AA, Ritter G, Odunsi K, Old LJ, Gnjatic S.
    J Immunol; 2012 Apr 15; 188(8):3851-8. PubMed ID: 22427632
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.
    Wang M, Tang ST, Stryhn A, Justesen S, Larsen MV, Dziegiel MH, Lewinsohn DM, Buus S, Lund O, Claesson MH.
    Immunology; 2011 Apr 15; 132(4):482-91. PubMed ID: 21294723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 93.